Clinical Trial Update: Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

View source ↗

Summary

Clinical trial update on potential biomarkers for bevacizumab-induced hypertension in patients with solid tumors; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Fallopian Tube Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer, Cardiovascular Complications | Status: TERMINATED